Amicus Therapeutics Inc. Stock
Amicus Therapeutics Inc. Stock
Amicus Therapeutics Inc. shows a slight decrease today, losing -€0.050 (-0.550%) compared to yesterday.
Amicus Therapeutics Inc. is currently one of the favorites of our community with 7 Buy predictions and no Sell predictions.
With a target price of 17 € there is a hugely positive potential of 87.85% for Amicus Therapeutics Inc. compared to the current price of 9.05 €.
So far the community has only identified positive things for Amicus Therapeutics Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Amicus Therapeutics Inc. in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
B****
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Amicus Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Amicus Therapeutics Inc. | -0.550% | 3.429% | -4.737% | -20.614% | -31.955% | 15.287% | - |
| Opko Health Inc. | 3.200% | 3.859% | 11.712% | 0.062% | -8.968% | -57.924% | -19.278% |
| Catalent Inc. | 0.650% | -1.861% | -5.237% | 40.652% | 20.340% | -40.265% | 22.269% |
| Repligen Corp. | -1.020% | -5.628% | -11.376% | -11.972% | -17.959% | -5.951% | - |
Comments
Amicus Therapeutics, Inc. (NASDAQ: FOLD) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating and a $18.00 price target on the stock.
Show more
Ratings data for FOLD provided by MarketBeat
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at UBS Group AG from $20.00 to $19.00. They now have a "buy" rating on the stock.
Show more
Ratings data for FOLD provided by MarketBeat
Amicus Therapeutics, Inc. (NASDAQ: FOLD) had its price target lowered by analysts at Morgan Stanley from $20.00 to $19.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for FOLD provided by MarketBeat